Basic Information
Basic information for PART1-202-35aa
Peptide Name PART1-202-35aa
Genome Position chr5:60547158-60547262[+]
Species Human
Peptide Sequence MVHVEAKKPKEFTKTVINILPLRSKSTLLCPVPRY
Peptide Length 35
Unique Yes
Grand Average of Hydropathicity -0.1029
Relative Molecular Mass 4650.53
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000152931;PART1
Transcript ID/Name ENST00000506884;PART1-202
Transcript Length 3240
Coding Ability 0.409
DNA Sequence Corresponding to Peptide ATGGTGCATGTGGAAGCTAAGAAGCCAAAGGAGTTCACCAAGACAGTTATCAATATATTGCCTCTCCGCTCCAAATCCACCCTTCTTTGCCCTGTTCCACGATAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :